Convey Health Solutions Holdings Inc (CNVY) Forecast, Price Target & Analyst Ratings
NYSE:CNVY • US21258C1080
10.51 USD
-0.05 (-0.47%)
At close: Oct 6, 2022
10.51 USD
0 (0%)
After Hours: 10/6/2022, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Convey Health Solutions Holdings Inc (CNVY).
Forecast Snapshot
Consensus Price Target
$11.22
+ 6.76% Upside
Next Earnings Forecast
Release DateNov 9, 2022
PeriodQ3 / 2022
EPS Estimate$0.09
Revenue Estimate100.068M
ChartMill Buy Consensus
48.89%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$11.22
Upside
+ 6.76%
From current price of $10.51 to mean target of $11.22, Based on 9 analyst forecasts
Low
$11.11
Median
$11.22
High
$11.55
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for CNVY. The average price target is 11.22 USD. This implies a price increase of 6.76% is expected in the next year compared to the current price of 10.51.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
48.89%
CNVY was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about CNVY.
In the previous month the buy percentage consensus was at a similar level.
CNVY was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-06-22 | Guggenheim | Downgrade | Buy -> Neutral |
| 2022-06-22 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2022-05-12 | Goldman Sachs | Maintains | Neutral |
| 2021-07-12 | Barclays | Initiate | Overweight |
| 2021-07-12 | Truist Securities | Initiate | Buy |
| 2021-07-12 | JP Morgan | Initiate | Neutral |
| 2021-07-12 | Canaccord Genuity | Initiate | Buy |
| 2021-07-12 | B of A Securities | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 9, 2022
PeriodQ3 / 2022
EPS Estimate$0.09
Revenue Estimate100.068M
Revenue Q2Q21.43%
EPS Q2Q83.60%
Number of Analysts8
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
CNVY is expected to report earnings on 11/9/2022. The consensus EPS estimate for the next earnings is 0.09 USD and the consensus revenue estimate is 100.07M USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 221.153M | 282.914M 27.93% | 337.596M 19.33% | 409.794M 21.39% | 475.775M 16.10% | 546.829M 14.93% | 619.297M 13.25% | 715.397M 15.52% | |
| EBITDA YoY % growth | 15.117M | 52.606M 247.99% | 51.913M -1.32% | 80.04M 54.18% | 95.991M 19.93% | 113.106M 17.83% | 131.823M 16.55% | 156.709M 18.88% | |
| EBIT YoY % growth | -7.43M | 24.574M 430.74% | 21.433M -12.78% | 36.414M 69.90% | 56.818M 56.03% | 74.601M 31.30% | 105.074M 40.85% | 150.955M 43.67% | |
| Operating Margin | -3.36% | 8.69% | 6.35% | 8.89% | 11.94% | 13.64% | 16.97% | 21.10% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.25 406.25% | 0.44 75.00% | 0.70 60.93% | 1.16 64.67% | 1.95 67.97% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 83.60% | 0.15 1,430.00% | 0.04 278.50% | 0.07 147.36% | 0.11 16.67% | 0.21 36.67% |
| Revenue Q2Q % growth | 100.068M 21.43% | 119.498M 22.81% | 106.82M 10.46% | 104.321M 16.19% | 116.28M 16.20% | 146.37M 22.49% |
| EBITDA Q2Q % growth | 22.175M -30.36% | 29.065M -29.39% | 14.994M 35.63% | 21.42M 46.37% | 24.582M 10.86% | 37.944M 30.55% |
| EBIT Q2Q % growth | 10.803M 17.75% | 17.779M 66.45% | 7.508M 167.86% | 8.924M 439.19% | 14.076M 30.30% | 27.336M 53.76% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
119.84%
EPS Next 5 Year
91.65%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
16.68%
Revenue Next 5 Year
15.76%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
Convey Health Solutions Holdings Inc / CNVY Forecast FAQ
What is the average price target for Convey Health Solutions Holdings Inc (CNVY) stock?
9 analysts have analysed CNVY and the average price target is 11.22 USD. This implies a price increase of 6.76% is expected in the next year compared to the current price of 10.51.
Can you provide the upcoming earnings date for Convey Health Solutions Holdings Inc?
Convey Health Solutions Holdings Inc (CNVY) will report earnings on 2022-11-09, after the market close.
What are the consensus estimates for Convey Health Solutions Holdings Inc (CNVY) next earnings?
The consensus EPS estimate for the next earnings of Convey Health Solutions Holdings Inc (CNVY) is 0.09 USD and the consensus revenue estimate is 100.07M USD.
Can you provide the expected long term growth rate for Convey Health Solutions Holdings Inc stock?
The expected long term growth rate for Convey Health Solutions Holdings Inc (CNVY) is 16.68%.